Literature DB >> 19732897

Associations of polymorphisms in the apolipoprotein A1/C3/A4/A5 gene cluster with familial combined hyperlipidaemia in Hong Kong Chinese.

Zhi-Kai Liu1, Miao Hu, Larry Baum, G Neil Thomas, Brian Tomlinson.   

Abstract

BACKGROUND: Familial combined hyperlipidaemia (FCH) is the most common genetic dyslipidaemia associated with coronary artery disease. Single nucleotide polymorphisms (SNPs) and haplotypes in the APOA1/C3/A4/A5 gene cluster are associated with FCH in Caucasians and with elevated triglycerides (TG) in various ethnic groups. We examined these associations with FCH in Hong Kong Chinese.
METHODS: Fifty-six Chinese FCH patients and 176 unrelated controls were studied. Thirteen SNPs in the APOA1/C3/A4/A5 cluster were genotyped.
RESULTS: Four alleles in APOA5 were associated with FCH (P<0.001). The -1131T>C (rs662799) and -3A>G (rs651821) SNPs in APOA5 were in almost complete linkage disequilibrium (LD, r(2)=0.99), and their minor alleles were more frequent (P<0.001) in FCH than controls (0.60 vs. 0.24). The odds ratio (OR) for FCH was 6.2 (95% CI, 2.6-14.8) and 6.1 (2.6-14.6) per copy of -1131C and -3G, respectively, and 24.6 (8.4-72.0) and 24.4 (8.4-70.9) in -1131C and -3G homozygotes, respectively, as compared to wild-type homozygotes. The 1891T>C (rs2266788) SNP was in LD (r(2)=0.68) with -1131T>C and -3A>G, and the minor allele was more frequent in FCH than controls (0.42 vs. 0.19, P<0.001). The 553G>T (rs2075291) nonsynonymous variant was also associated with FCH (0.15 vs. 0.04, P=0.001) and, along with -3A>G (or -1131T>C) and 1891T>C, contributed to haplotypes predicting FCH. The two tightly linked SNPs, -1131T>C and -3A>G polymorphism were significantly associated with lipid traits in all subjects combined, with variant homozygous subjects having higher TG and LDL-C and lower HDL-C levels.
CONCLUSIONS: Some common polymorphisms and haplotypes in APOA5 are closely associated with FCH in Hong Kong Chinese, and these differ from those found in Caucasians. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19732897     DOI: 10.1016/j.atherosclerosis.2009.08.013

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  21 in total

Review 1.  The genetics of familial combined hyperlipidaemia.

Authors:  Martijn C G J Brouwers; Marleen M J van Greevenbroek; Coen D A Stehouwer; Jacqueline de Graaf; Anton F H Stalenhoef
Journal:  Nat Rev Endocrinol       Date:  2012-02-14       Impact factor: 43.330

Review 2.  Unravelling the effects of the environment and host genotype on the gut microbiome.

Authors:  Aymé Spor; Omry Koren; Ruth Ley
Journal:  Nat Rev Microbiol       Date:  2011-04       Impact factor: 60.633

3.  A single nucleotide polymorphism in APOA5 determines triglyceride levels in Hong Kong and Guangzhou Chinese.

Authors:  Chao Qiang Jiang; Bin Liu; Bernard M Y Cheung; Tai Hing Lam; Jie Ming Lin; Ya Li Jin; Xiao Jun Yue; Kwok Leung Ong; Sidney Tam; Ka Sing Wong; Brian Tomlinson; Karen S L Lam; G Neil Thomas
Journal:  Eur J Hum Genet       Date:  2010-06-23       Impact factor: 4.246

4.  Common functional variants of APOA5 and GCKR accumulate gradually in association with triglyceride increase in metabolic syndrome patients.

Authors:  Ferenc Hadarits; Péter Kisfali; Márton Mohás; Anita Maász; Balázs Duga; Ingrid Janicsek; István Wittmann; Béla Melegh
Journal:  Mol Biol Rep       Date:  2011-06-04       Impact factor: 2.316

5.  Stepwise positive association between APOA5 minor allele frequencies and increasing plasma triglyceride quartiles in random patients with hypertriglyceridemia of unclarified origin.

Authors:  Ferenc Hadarits; Péter Kisfali; Márton Mohás; Anita Maász; Katalin Sümegi; Melinda Szabó; Katalin Hetyésy; Andrea Valasek; Ingrid Janicsek; István Wittmann; Béla Melegh
Journal:  Pathol Oncol Res       Date:  2010-05-19       Impact factor: 3.201

Review 6.  The paradox of ApoA5 modulation of triglycerides: evidence from clinical and basic research.

Authors:  Mahdi Garelnabi; Kenton Lor; Jun Jin; Fei Chai; Nalini Santanam
Journal:  Clin Biochem       Date:  2012-09-19       Impact factor: 3.281

Review 7.  Genetics of Familial Combined Hyperlipidemia (FCHL) Disorder: An Update.

Authors:  Eskandar Taghizadeh; Najmeh Farahani; Rajab Mardani; Forough Taheri; Hassan Taghizadeh; Seyed Mohammad Gheibihayat
Journal:  Biochem Genet       Date:  2021-09-03       Impact factor: 1.890

8.  Single nucleotide polymorphisms in CETP, SLC46A1, SLC19A1, CD36, BCMO1, APOA5, and ABCA1 are significant predictors of plasma HDL in healthy adults.

Authors:  Andrew J Clifford; Gonzalo Rincon; Janel E Owens; Juan F Medrano; Alanna J Moshfegh; David J Baer; Janet A Novotny
Journal:  Lipids Health Dis       Date:  2013-05-08       Impact factor: 3.876

9.  Associations of polymorphisms in the apolipoprotein APOA1-C3-A5 gene cluster with acute coronary syndrome.

Authors:  Yan Ding; Ming An Zhu; Zhi Xiao Wang; Jing Zhu; Jing Bo Feng; Dong Sheng Li
Journal:  J Biomed Biotechnol       Date:  2012-05-23

Review 10.  The Genetic Basis of Hypertriglyceridemia.

Authors:  Germán D Carrasquilla; Malene Revsbech Christiansen; Tuomas O Kilpeläinen
Journal:  Curr Atheroscler Rep       Date:  2021-06-19       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.